Tamir Biotechnology, Inc.·4

Jun 8, 2:40 PM ET

WEISS PAUL M 4

4 · Tamir Biotechnology, Inc. · Filed Jun 8, 2011

Insider Transaction Report

Form 4
Period: 2011-06-06
WEISS PAUL M
Director
Transactions
  • Award

    Common Stock (Right to Buy)

    2011-06-06+125,000125,000 total
    Exercise: $0.12From: 2011-12-31Exp: 2016-12-31Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]Issued under the Company's 2004 Stock Incentive Plan and qualified under Rule 16b-3(d).

Documents

1 file
  • 4
    q11-00414.xmlPrimary

    FORM 4 - WEISS